MN
·MeSH: Glomerulonephritis, Membranous
35 drugs in development·24 companies·1 clinical trial
Drug Pipeline by Phase
Approved(12)
Phase 3(10)
Phase 2(5)
Phase 1(1)
| Drug | Company |
|---|---|
| VK0214 | Viking Therapeutics, Inc. (VKTX) |
Preclinical(3)
N/A(2)
Phase 2/Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for MN?
BioSniper tracks 35 drugs in development for MN across 24 companies.
How many clinical trials target MN?
There are 1 clinical trial targeting MN tracked by BioSniper.
Deep-dive into MN
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis